A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma is a research paper published in Tomography (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI
Grant: R01 CA214557
NCI
Grant: U01 CA264039
NCI
Grant: R01 NS121544
NCI
Grant: F31CA247564
NIGMS NIH HHS
Grant: T32 GM142617
National Institutes of Health
Grant: 5U01CA264039-06
Improved whole-brain spectroscopic MRI for radiation therapy planning
National Institutes of Health
Grant: 1F31CA247564-01
Automated imaging analysis tools to guide clinical decision making in brain tumor patients
National Institutes of Health
Grant: 5R01CA214557-03
Spectroscopic MRI to guide radiation dose escalation for glioblastoma patients
National Institutes of Health
Grant: 5R01NS121544-03
Unified Shim-RF Coil Technology for Improved Whole-Brain Spectroscopic MRI for Neurological Disorders
RSNA Research & Education Foundation
FWCI
0.34
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals